Chemists at MIT have created a triple warhead against cancer. They believe theirs is the first example a polymer nanoparticle which carries a precise ratio of three drugs that can be released in response to three distinct triggers.
A new Belgian company has joined the throng of pharmas tapping into
the booming drug delivery business, but claims that its unique
technologies will carve it a place as one of the industry's key
Amgen will strengthen its drug portfolio aimed at fighting renal
disease after agreeing to acquire Ilypsa, a private biotechnology
company which is developing a novel drug for the treatment of
elevated blood phosphate (hyperphosphataemia)...
Pfizer has issued another recall for packs of its blockbuster
cholesterol drug Lipitor after UK regulators found evidence of more
counterfeit product in the legitimate supply chain from a batch
whose withdrawal was supposed to have...
A new laboratory test that identifies patients who benefit most
from targeted cancer drugs was the talk of the annual meeting of
the American Society of Clinical Oncology (ASCO) as the test's
accuracy is sure to save hundreds...
While praising the benefits of radio-frequency identification
(RFID), the US Food and Drug Administration (FDA) has refrained
from demanding its implementation in new measures it unveiled to
combat counterfeit drugs, asking instead...
The US Food and Drug Administration (FDA) has linked its
Counterfeit Alert Network (CAN) to SafeMeds Alert System, an
electronic mailing list backed by pharmaceutical manufacturers that
sends warnings about fake drugs to anyone who...
Bruker Optics have reached an agreement with the Chinese State Food
and Drug Administration (SFDA), which sees Bruker technology
integrated into regional Food and Drug Administration offices
aiding the fight against illegal counterfeit...
Scientists have discovered the antimonial drugs used to treat
Leishmaniasis focus on the same drug targets as those drugs used to
treat sleeping sickness and Chagas disease, raising the possibility
of a multi-functional drug that...
The cost and time required to develop a new drug and bring it to
market is determined by the therapeutic category of that drug. The
results are consistent with the model that predicts R&D efforts
are generally shifting toward...
In response to growing concerns about counterfeit drugs in the US
drug supply, an industry group has submitted a report to the Food
and Drug Administration (FDA) as a commentary on policy issues
surrounding prescription drug counterfeiting,...